Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Planning permission received

20 Sep 2011 09:29

RNS Number : 5572O
Derwent London PLC
20 September 2011
 



 

20 September 2011

 

 

Derwent London plc ("Derwent London" / "the Group")

 

MAYOR OF LONDON APPROVES MAJOR FITZROVIAREGENERATION PROJECT

 

Derwent London is pleased to announce that it has been granted planning permission by the Mayor of London for a major mixed use development at 80 Charlotte Street, Fitzrovia W1. The 367,000 sq ft (34,100m2) redevelopment will include 336,000 sq ft (31,200m²) of office, residential and retail space at 80 Charlotte Street and 31,000 sq ft (2,900m²) of residential at nearby 65 Whitfield Street and 1-8 Whitfield Place. In addition, a new public realm park will be created whilst retail units will enhance the ground floor frontage and identity.

 

The new scheme has been designed by leading architects Make and will be part refurbishment and part new build with a substantial proportion of the existing structures retained thereby cutting waste and carbon emissions whilst reducing the construction period.

 

80 Charlotte Street is an island site of 1.4 acres that is located in the heart of Fitzrovia. It currently comprises 200,000 sq ft (18,600m2) of out-dated offices which are let to Saatchi & Saatchi until March 2013. The new scheme, with anticipated capital expenditure of circa £125 million, is expected to be delivered towards the end of 2015 and will be a major step in the wider regeneration of the area where the Group's holdings total over 1.5 million sq ft.

 

John Burns, Chief Executive at Derwent London, commented:

 

"We are pleased that our 80 Charlotte Street planning application has been approved by the Mayor of London. This is a significant scheme for the Group and gives us the opportunity to transform the existing buildings into high quality offices that will form an exciting new office hub in keeping with the Derwent brand. The park and ground floor retail space will create new life and character to the streets of Fitzrovia and the new residential units, that include affordable housing, will provide a high quality living environment. We look forward to starting on site in 2013."

 

 

 

Notes to editors

 

Derwent London plc

 

Derwent London plc is the largest central London focused REIT with an investment portfolio of £2.6bn as at 30 June 2011. The Group is one of London's most innovative office specialist property regenerators and investors and is well known for its design-led philosophy and creative management approach to development.

 

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment, regeneration and redevelopment. The Group owns and manages an investment portfolio of 5.4 million sq ft (505,000m2), as at 30 June 2011, of which 96% is located in central London, with a specific focus on the West End and the areas bordering the City of London. Landmark schemes by Derwent London include the Angel Building EC1, Arup Phases II & III W1, Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

 

Derwent London came first in the property sector in the 2010 awards for 'Britain's Most Admired Companies'. This year, the Angel Building has been shortlisted for the RIBA Stirling Prize following its RIBA London 2011 award and has also won accolades from the British Council for Offices and New London Architecture. The recent Maple & Fitzroy development in Fitzrovia W1 also won a 2011 RIBA London and New London Architecture award.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIGDCIDDBGBG
Date   Source Headline
28th Feb 20237:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
31st Jan 202311:30 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSDirector Declaration
20th Jan 20232:50 pmRNSHolding(s) in Company
19th Jan 20232:30 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSSale of 19 Charterhouse Street EC1
30th Dec 20221:15 pmRNSTotal Voting Rights
6th Dec 20224:00 pmRNSHolding(s) in Company
30th Nov 20224:30 pmRNSTotal Voting Rights
16th Nov 202212:15 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSThird Quarter Business Update
31st Oct 20224:45 pmRNSTotal Voting Rights
19th Oct 20223:31 pmRNSDirector/PDMR Shareholding
13th Oct 20225:20 pmRNSHolding(s) in Company
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:45 pmRNSTotal Voting Rights
21st Sep 20225:00 pmRNSDirector/PDMR Shareholding
20th Sep 20224:30 pmRNSBlock listing Interim Review
31st Aug 20224:45 pmRNSTotal Voting Rights
25th Aug 20229:15 amRNSAdditional Listing
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202210:30 amRNSHolding(s) in Company
11th Aug 20227:00 amRNSUnaudited Results for six months ended 30.06.22
10th Aug 20224:30 pmRNSHolding(s) in Company
2nd Aug 20223:45 pmRNSHolding(s) in Company
29th Jul 20224:45 pmRNSTotal Voting Rights
26th Jul 20225:15 pmRNSHolding(s) in Company
21st Jul 20223:00 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSDisposal of Bush House WC2
30th Jun 20224:45 pmRNSTotal Voting Rights
9th Jun 202210:00 amRNSAdditional Listing
6th Jun 20222:00 pmRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSTotal Voting Rights
26th May 20223:10 pmRNSHolding(s) in Company
24th May 20225:10 pmRNSHolding(s) in Company
13th May 20221:00 pmRNSResult of AGM
10th May 20229:00 amRNSBondholders' Meeting
5th May 20227:01 amRNSCity Road Island EC1 Exchange of Contract
5th May 20227:00 amRNSQ1 2022 Business Update
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing
2nd Mar 20229:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.